Company Filing History:
2 out of 15 
2 out of 2,939 
1 out of 3 Years Active: 2005-2013
Title: The Innovative Journey of Inventor Yan Lan
Introduction
Yan Lan, an accomplished inventor based in Belmont, MA, has made significant contributions to the field of biomedical innovations, particularly in cancer treatment. With a total of six patents to her name, she is recognized for her groundbreaking work that combines molecular biology and immunotherapy.
Latest Patents
Two of Yan Lan's latest patents exemplify her innovative spirit and commitment to improving medical treatments. The first patent focuses on "Interleukin-12 targeted to oncofoetal fibronectin," which provides a compound composed of a target-specific portion and an effector portion. This invention outlines a method for employing monoclonal antibodies specific to oncofoetal fibronectin to enhance cancer treatment efficacy. The second patent, "Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation," discusses the production of fusion proteins using interleukin-12. It details a unique genetic engineering method to ensure the proper ratio of components, resulting in the creation of active heterodimeric fusion proteins essential for targeted immune therapies.
Career Highlights
Throughout her career, Yan Lan has been associated with reputable companies such as EMD Lexigen Research Center Corporation and Merck Patent GmbH. Her work at these institutions has not only advanced her professional journey but has also contributed to the development of innovative therapeutic solutions.
Collaborations
Collaboration has played a vital role in Yan Lan's success. She has worked alongside esteemed colleagues like Stephen D. Gillies and Kin-Ming Lo, enhancing her projects through shared expertise and innovative ideas. These partnerships underscore the importance of teamwork in driving advancements in the scientific field.
Conclusion
Yan Lan's journey as an inventor showcases her dedication to scientific innovation and her impact on medical research. With her groundbreaking patents and collaborations, she continues to pave the way for advancements in cancer treatment, making her a valuable asset to the field of biomedical engineering. As she moves forward, her contributions are likely to lead to even more significant discoveries and improvements in healthcare.